These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24603468)

  • 1. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.
    Bashirova AA; Martin-Gayo E; Jones DC; Qi Y; Apps R; Gao X; Burke PS; Taylor CJ; Rogich J; Wolinsky S; Bream JH; Duggal P; Hussain S; Martinson J; Weintrob A; Kirk GD; Fellay J; Buchbinder SP; Goedert JJ; Deeks SG; Pereyra F; Trowsdale J; Lichterfeld M; Telenti A; Walker BD; Allen RL; Carrington M; Yu XG
    PLoS Genet; 2014 Mar; 10(3):e1004196. PubMed ID: 24603468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
    Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
    J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.
    Alaoui L; Palomino G; Zurawski S; Zurawski G; Coindre S; Dereuddre-Bosquet N; Lecuroux C; Goujard C; Vaslin B; Bourgeois C; Roques P; Le Grand R; Lambotte O; Favier B
    Cell Mol Life Sci; 2018 May; 75(10):1871-1887. PubMed ID: 29134249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
    Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.
    McIntire RH; Sifers T; Platt JS; Ganacias KG; Langat DK; Hunt JS
    Placenta; 2008 Jul; 29(7):631-8. PubMed ID: 18538388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.
    Jones DC; Kosmoliaptsis V; Apps R; Lapaque N; Smith I; Kono A; Chang C; Boyle LH; Taylor CJ; Trowsdale J; Allen RL
    J Immunol; 2011 Mar; 186(5):2990-7. PubMed ID: 21270408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity of the LILRB1 and LILRB2 coding regions in an admixed Brazilian population sample.
    Oliveira MLG; Castelli EC; Veiga-Castelli LC; Pereira ALE; Marcorin L; Carratto TMT; Souza AS; Andrade HS; Simões AL; Donadi EA; Courtin D; Sabbagh A; Giuliatti S; Mendes-Junior CT
    HLA; 2022 Oct; 100(4):325-348. PubMed ID: 35754199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection.
    Huang J; Al-Mozaini M; Rogich J; Carrington MF; Seiss K; Pereyra F; Lichterfeld M; Yu XG
    Retrovirology; 2012 Jan; 9():11. PubMed ID: 22289474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.
    Lazaryan A; Song W; Lobashevsky E; Tang J; Shrestha S; Zhang K; McNicholl JM; Gardner LI; Wilson CM; Klein RS; Rompalo A; Mayer K; Sobel J; Kaslow RA; ;
    Hum Immunol; 2011 Apr; 72(4):312-8. PubMed ID: 21262311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of HLA class I antigen specificities and haplotypes with disease progression in HIV-1-infected Hans in Northern China.
    Zhang H; Zhao B; Han X; Wang Z; Liu B; Lu C; Zhang M; Liu J; Chen O; Hu Q; Jiang F; Shang H
    Hum Immunol; 2013 Dec; 74(12):1636-42. PubMed ID: 24012585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
    ; Pereyra F; Jia X; McLaren PJ; Telenti A; de Bakker PI; Walker BD; Ripke S; Brumme CJ; Pulit SL; Carrington M; Kadie CM; Carlson JM; Heckerman D; Graham RR; Plenge RM; Deeks SG; Gianniny L; Crawford G; Sullivan J; Gonzalez E; Davies L; Camargo A; Moore JM; Beattie N; Gupta S; Crenshaw A; Burtt NP; Guiducci C; Gupta N; Gao X; Qi Y; Yuki Y; Piechocka-Trocha A; Cutrell E; Rosenberg R; Moss KL; Lemay P; O'Leary J; Schaefer T; Verma P; Toth I; Block B; Baker B; Rothchild A; Lian J; Proudfoot J; Alvino DM; Vine S; Addo MM; Allen TM; Altfeld M; Henn MR; Le Gall S; Streeck H; Haas DW; Kuritzkes DR; Robbins GK; Shafer RW; Gulick RM; Shikuma CM; Haubrich R; Riddler S; Sax PE; Daar ES; Ribaudo HJ; Agan B; Agarwal S; Ahern RL; Allen BL; Altidor S; Altschuler EL; Ambardar S; Anastos K; Anderson B; Anderson V; Andrady U; Antoniskis D; Bangsberg D; Barbaro D; Barrie W; Bartczak J; Barton S; Basden P; Basgoz N; Bazner S; Bellos NC; Benson AM; Berger J; Bernard NF; Bernard AM; Birch C; Bodner SJ; Bolan RK; Boudreaux ET; Bradley M; Braun JF; Brndjar JE; Brown SJ; Brown K; Brown ST; Burack J; Bush LM; Cafaro V; Campbell O; Campbell J; Carlson RH; Carmichael JK; Casey KK; Cavacuiti C; Celestin G; Chambers ST; Chez N; Chirch LM; Cimoch PJ; Cohen D; Cohn LE; Conway B; Cooper DA; Cornelson B; Cox DT; Cristofano MV; Cuchural G; Czartoski JL; Dahman JM; Daly JS; Davis BT; Davis K; Davod SM; DeJesus E; Dietz CA; Dunham E; Dunn ME; Ellerin TB; Eron JJ; Fangman JJ; Farel CE; Ferlazzo H; Fidler S; Fleenor-Ford A; Frankel R; Freedberg KA; French NK; Fuchs JD; Fuller JD; Gaberman J; Gallant JE; Gandhi RT; Garcia E; Garmon D; Gathe JC; Gaultier CR; Gebre W; Gilman FD; Gilson I; Goepfert PA; Gottlieb MS; Goulston C; Groger RK; Gurley TD; Haber S; Hardwicke R; Hardy WD; Harrigan PR; Hawkins TN; Heath S; Hecht FM; Henry WK; Hladek M; Hoffman RP; Horton JM; Hsu RK; Huhn GD; Hunt P; Hupert MJ; Illeman ML; Jaeger H; Jellinger RM; John M; Johnson JA; Johnson KL; Johnson H; Johnson K; Joly J; Jordan WC; Kauffman CA; Khanlou H; Killian RK; Kim AY; Kim DD; Kinder CA; Kirchner JT; Kogelman L; Kojic EM; Korthuis PT; Kurisu W; Kwon DS; LaMar M; Lampiris H; Lanzafame M; Lederman MM; Lee DM; Lee JM; Lee MJ; Lee ET; Lemoine J; Levy JA; Llibre JM; Liguori MA; Little SJ; Liu AY; Lopez AJ; Loutfy MR; Loy D; Mohammed DY; Man A; Mansour MK; Marconi VC; Markowitz M; Marques R; Martin JN; Martin HL; Mayer KH; McElrath MJ; McGhee TA; McGovern BH; McGowan K; McIntyre D; Mcleod GX; Menezes P; Mesa G; Metroka CE; Meyer-Olson D; Miller AO; Montgomery K; Mounzer KC; Nagami EH; Nagin I; Nahass RG; Nelson MO; Nielsen C; Norene DL; O'Connor DH; Ojikutu BO; Okulicz J; Oladehin OO; Oldfield EC; Olender SA; Ostrowski M; Owen WF; Pae E; Parsonnet J; Pavlatos AM; Perlmutter AM; Pierce MN; Pincus JM; Pisani L; Price LJ; Proia L; Prokesch RC; Pujet HC; Ramgopal M; Rathod A; Rausch M; Ravishankar J; Rhame FS; Richards CS; Richman DD; Rodes B; Rodriguez M; Rose RC; Rosenberg ES; Rosenthal D; Ross PE; Rubin DS; Rumbaugh E; Saenz L; Salvaggio MR; Sanchez WC; Sanjana VM; Santiago S; Schmidt W; Schuitemaker H; Sestak PM; Shalit P; Shay W; Shirvani VN; Silebi VI; Sizemore JM; Skolnik PR; Sokol-Anderson M; Sosman JM; Stabile P; Stapleton JT; Starrett S; Stein F; Stellbrink HJ; Sterman FL; Stone VE; Stone DR; Tambussi G; Taplitz RA; Tedaldi EM; Telenti A; Theisen W; Torres R; Tosiello L; Tremblay C; Tribble MA; Trinh PD; Tsao A; Ueda P; Vaccaro A; Valadas E; Vanig TJ; Vecino I; Vega VM; Veikley W; Wade BH; Walworth C; Wanidworanun C; Ward DJ; Warner DA; Weber RD; Webster D; Weis S; Wheeler DA; White DJ; Wilkins E; Winston A; Wlodaver CG; van't Wout A; Wright DP; Yang OO; Yurdin DL; Zabukovic BW; Zachary KC; Zeeman B; Zhao M
    Science; 2010 Dec; 330(6010):1551-7. PubMed ID: 21051598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
    Martin MP; Qi Y; Gao X; Yamada E; Martin JN; Pereyra F; Colombo S; Brown EE; Shupert WL; Phair J; Goedert JJ; Buchbinder S; Kirk GD; Telenti A; Connors M; O'Brien SJ; Walker BD; Parham P; Deeks SG; McVicar DW; Carrington M
    Nat Genet; 2007 Jun; 39(6):733-40. PubMed ID: 17496894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes.
    Qin K; Boppana S; Carlson JM; Fiore-Gartland A; Files J; Zeng J; Edberg J; Mailliard RB; Ochsenbauer C; Bansal A; Goepfert P
    J Virol; 2021 Jul; 95(16):e0016021. PubMed ID: 34076482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA A03 Supertype and Several
    de Groot NG; Heijmans CMC; de Ru AH; Otting N; Koning F; van Veelen PA; Bontrop RE
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for natural selection on leukocyte immunoglobulin-like receptors for HLA class I in Northeast Asians.
    Hirayasu K; Ohashi J; Tanaka H; Kashiwase K; Ogawa A; Takanashi M; Satake M; Jia GJ; Chimge NO; Sideltseva EW; Tokunaga K; Yabe T
    Am J Hum Genet; 2008 May; 82(5):1075-83. PubMed ID: 18439545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the CD8
    Killian MS; Teque F; Sudhagoni R
    Immunogenetics; 2018 Feb; 70(2):99-113. PubMed ID: 28735348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.